Research Model: Computational Modeling

Dr. Xiao Tian participates in the Degenerative Diseases Program and the Cancer Genome and Epigenetics Program at Sanford Burnham Prebys. He started his lab in 2024 to understand the fundamental biology of aging and its contribution to age-related diseases. He joined the Institute after his postdoctoral research in Dr. David Sinclair’s lab at Harvard Medical School where he co-wrote the Information Theory of Aging. He obtained his BS from Shandong University and his PhD from the University of Rochester where he worked with Dr. Vera Gorbunova.
 

Education

2018-2023: Postdoc, Harvard Medical School
2016-2018: Postdoc, University of Rochester
2010-2016: PhD, Biology of Aging, University of Rochester
2005-2009: BS, Microbial Technology, Shandong University
 

Honors and Awards

2020-2026: K99/R00 Pathway to Independence Awards, NIH/NIA
2019-2020: NASA Postdoctoral Fellowship, NASA Ames Research Center
2017: Outstanding Dissertation Award for the Natural Sciences, University of Rochester
2015: Messersmith Dissertation Fellowship, University of Rochester
2014: Award for Outstanding Self-Financed Students Abroad, China Scholarship Council
2010-2014: Holtfreter Fellowship, University of Rochester
2007: Weichai Power Scholarship, Shandong University
2006-2008: Excellent Student Scholarship, Shandong University

Related Disease
Aging-Related Diseases, Alzheimer’s Disease, Cancer

Phenomena or Processes
Aging, Epigenetics, Genomic Instability, Neurodegeneration

Research Models
Computational Modeling, Mouse, Naked Mole Rat, Primary Human Cells

Techniques and Technologies
Bioinformatics, Epigenomics, Gene Expression, Gene Knockout (Complete and Conditional), High-Throughput/Robotic Screening, Mouse Behavioral Analysis

The Tian lab studies the fundamental mechanisms of aging and their roles in the onset of age-related diseases. Our recent research in epigenetic reprogramming and aging clocks indicates that the progressive loss of epigenetic information over time is a key driver of aging. The current research of the lab focuses on understanding how the epigenetic landscape is set up and maintained and investigating why the maintenance system fails which leads to aging and related diseases including cancer and neurodegeneration. Building on this, our ultimate goal is to develop safe and effective rejuvenation strategies to counteract aging.

Xiao Tian’s Research Report

Below are my major contributions to the field of aging research during my PhD and postdoc work:

Uncovering the first anti-cancer and longevity mechanism of the naked mole rat
We identified high-molecular-mass hyaluronan (HMM HA) as a critical mechanism for the cancer resistance of the naked mole-rat cells. Furthermore, we found that this anti-cancer and longevity mechanism from naked mole rats can be integrated into other species, highlighting the significant implications of identifying new mechanisms from long-lived species. Our goal is to decipher how long-lived organisms control the pace of aging and deter age-related diseases.
 

Discovering enhanced DNA double-strand break (DSB) repair in long-lived species
Using a group of 18 species, we revealed that long-lived species possess efficient DNA double-strand break repair, mediated by potent SIRT6 activities. Future directions include deciphering how long-lived species address different types of cellular stress to maintain genomic and epigenomic stability.
 

Epigenetic reprogramming as a strategy to counteract aging and age-related diseases
We illustrated that epigenetic information loss as a result of DNA damage repair is a key driver of aging. One interventional strategy is to recover the lost epigenetic information, such as through reprogramming. We revealed that epigenetic reprogramming is an effective strategy to counteract aging and even potentially modify the trajectory of age-related diseases including glaucoma. We are currently testing other disease settings.